Bloomberg’s John Tucker focuses on three stocks for the week ahead. They include: Paramount Skydance (PSKY) Hims & Hers (HIMS) and TakeTwo Interactive (TTWO)

John previews what to expect from these companies in the week ahead with Norah Mulinda, Bloomberg Television Markets Correspondent.

Bloomberg&rsquo;s John Tucker focuses on three stocks for the week ahead. They include: Paramount Skydance (PSKY)&nbsp;Hims &amp; Hers (HIMS) and TakeTwo Interactive (TTWO)
John previews what to expect from these companies in the week ahead with Norah Mulinda, Bloomberg Television Markets Correspondent.

Listen for Short conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for Short conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Listen for short conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for short conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Week Ahead: Paramount Skydance, Hims & Hers, Take-Two Interactive

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a40d3ced-e37c-440a-a756-b4fa015071bb/transcript

Today's biggest winners and losers in the stock market, a look at the notable movers: 
On this episode of Stock Movers:

- Marvell Technology this week announced plans to acquire Lumentum Holdings at a valuation of $115 billion. Shares of Lumentum and Marvell were on pace for historically poor weekly performances, with Lumentum declining 37% and Marvell falling more than 29% by midday Friday. The selloff has called into question the valuation of Marvell's all-stock offer for Lumentum, with Lumentum stock closing 55% below the implied valuation of $1,132 per share.

- CleanSpark Inc. stock surged by over 11% on Tuesday alongside a technical rebound and a cryptocurrency relief rally lifting Bitcoin. The company faces its next estimated earnings report on Nov. 24, with consensus forecasts projecting an earnings loss of 24 cents per stock on estimated revenue of $133.58 million.

- AppLovin (APP) shares this week were up 34% despite a broader tech selloff after the company issued third-quarter results that topped estimates and issued a fourth-quarter outlook above expectations.

Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers: - Marvell Technology this week announced plans to acquire Lumentum Holdings at a valuation of $115 billion. Shares of Lumentum and Marvell were on pace for historically poor weekly performances, with Lumentum declining 37% and Marvell falling more than 29% by midday Friday. The selloff has called into question the valuation of Marvell's all-stock offer for Lumentum, with Lumentum stock closing 55% below the implied valuation of $1,132 per share. - CleanSpark Inc. stock surged by over 11% on Tuesday alongside a technical rebound and a cryptocurrency relief rally lifting Bitcoin. The company faces its next estimated earnings report on Nov. 24, with consensus forecasts projecting an earnings loss of 24 cents per stock on estimated revenue of $133.58 million. - AppLovin (APP) shares this week were up 34% despite a broader tech selloff after the company issued third-quarter results that topped estimates and issued a fourth-quarter outlook above expectations.

 Weekly Roundup: Marvell, Cleanspark, Applovin

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/246df7d9-e668-491f-b8ce-b4fa016c5a4c/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Tim Stenovec, Carol Massar
- Airbnb (ABNB) Chief Executive Officer Brian Chesky said his company is back in “growth mode” after it posted the fastest revenue gain in three years. The company now expects full-year revenue to grow in the “high teens” and lifted its full-year margin forecast for adjusted earnings before interest, taxes, depreciation and amortization to about 36%. Airbnb announced a new repurchase authorization of as much as $12 billion more in stock and shares jumped more than 10% in extended trading after the release.

- Moderna (MRNA) boosted its full-year guidance and posted its first quarterly profit since 2024 as Covid vaccine sales rebounded strongly from a year ago. The company is trying to open a new source of growth by refocusing on cancer drug development, with a successful late-stage trial of an mRNA-based skin cancer vaccine with Merck & Co. Moderna anticipates filing a US marketing application for the cancer drug, called intismeran, by the end of the year, which could lead to approval in 2027.

- DraftKings (DKNG) shares fell as much as 29% on Friday after the company sharply reduced its profit forecast as a result of continued investment in its prediction-market product. The company now expects revenue of as much as $6.55 billion and adjusted earnings before interest, tax, depreciation and amortization up to $275 million for fiscal year 2026. DraftKings reported revenue of $1.33 billion in the third quarter, missing analysts’ estimates of $1.39 billion, and sees adjusted Ebidta for 2027 of $800 million to $1 billion.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Tim Stenovec, Carol Massar - Airbnb (ABNB) Chief Executive Officer Brian Chesky said his company is back in &ldquo;growth mode&rdquo; after it posted the fastest revenue gain in three years. The company now expects full-year revenue to grow in the &ldquo;high teens&rdquo; and lifted its full-year margin forecast for adjusted earnings before interest, taxes, depreciation and amortization to about 36%. Airbnb announced a new repurchase authorization of as much as $12 billion more in stock and shares jumped more than 10% in extended trading after the release. - Moderna (MRNA) boosted its full-year guidance and posted its first quarterly profit since 2024 as Covid vaccine sales rebounded strongly from a year ago. The company is trying to open a new source of growth by refocusing on cancer drug development, with a successful late-stage trial of an mRNA-based skin cancer vaccine with Merck &amp; Co. Moderna anticipates filing a US marketing application for the cancer drug, called intismeran, by the end of the year, which could lead to approval in 2027. - DraftKings (DKNG) shares fell as much as 29% on Friday after the company sharply reduced its profit forecast as a result of continued investment in its prediction-market product. The company now expects revenue of as much as $6.55 billion and adjusted earnings before interest, tax, depreciation and amortization up to $275 million for fiscal year 2026. DraftKings reported revenue of $1.33 billion in the third quarter, missing analysts&rsquo; estimates of $1.39 billion, and sees adjusted Ebidta for 2027 of $800 million to $1 billion.

Closing Bell: Airbnb, Moderna Jump; DraftKings Plunges

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2e48d3e2-07c4-458a-aa5d-b4fa015e38ca/transcript

Today's biggest winners and losers in the stock market, a look at the notable movers: 
On this episode of Stock Movers:

- Airbnb (ABNB) Chief Executive Officer Brian Chesky said his company is back in “growth mode” after it posted the fastest revenue gain in three years. The company now expects full-year revenue to grow in the “high teens” and lifted its full-year margin forecast for adjusted earnings before interest, taxes, depreciation and amortization to about 36%. Airbnb announced a new repurchase authorization of as much as $12 billion more in stock and shares jumped more than 10% in extended trading after the release.

- Moderna (MRNA) boosted its full-year guidance and posted its first quarterly profit since 2024 as Covid vaccine sales rebounded strongly from a year ago. The company is trying to open a new source of growth by refocusing on cancer drug development, with a successful late-stage trial of an mRNA-based skin cancer vaccine with Merck & Co. Moderna anticipates filing a US marketing application for the cancer drug, called intismeran, by the end of the year, which could lead to approval in 2027.

- Oracle (ORCL) shares are falling after a report that Microsoft is pulling back from a deal to lease AI computing power from the company. Microsoft has been switching off the leased capacity over recent months, after deciding not to extend the contract, according to sources. Oracle stock is trading near its 52-week low of $111.66, and is testing lower boundaries.

Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers: - Airbnb (ABNB) Chief Executive Officer Brian Chesky said his company is back in &ldquo;growth mode&rdquo; after it posted the fastest revenue gain in three years. The company now expects full-year revenue to grow in the &ldquo;high teens&rdquo; and lifted its full-year margin forecast for adjusted earnings before interest, taxes, depreciation and amortization to about 36%. Airbnb announced a new repurchase authorization of as much as $12 billion more in stock and shares jumped more than 10% in extended trading after the release. - Moderna (MRNA) boosted its full-year guidance and posted its first quarterly profit since 2024 as Covid vaccine sales rebounded strongly from a year ago. The company is trying to open a new source of growth by refocusing on cancer drug development, with a successful late-stage trial of an mRNA-based skin cancer vaccine with Merck &amp; Co. Moderna anticipates filing a US marketing application for the cancer drug, called intismeran, by the end of the year, which could lead to approval in 2027. - Oracle (ORCL) shares are falling after a report that Microsoft is pulling back from a deal to lease AI computing power from the company. Microsoft has been switching off the leased capacity over recent months, after deciding not to extend the contract, according to sources. Oracle stock is trading near its 52-week low of $111.66, and is testing lower boundaries.

Airbnb Jumps, Moderna Gains, Oracle Sinks

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/09168763-7a34-4421-89e2-b4fa014a4ae2/transcript

Week Ahead: Paramount Skydance, Hims & Hers, Take-Two Interactive

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips